Elagolix
Top View
- 2021 Aetna Standard Plan
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- Endometriosis and Medical Therapy: from Progestogens to Progesterone Resistance to Gnrh Antagonists: a Review
- Luteinizing Hormone-Releasing Hormone Antagonists
- Elagolix | Memorial Sloan Kettering Cancer Center
- Endoshare: Personalizing Treatment of Endometriosis
- Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy Ayman Al‑Hendy, M.D., Ph.D., Andrea S
- How Effective Is Elagolix Treatment in Women with Fibroids and HMB?
- M12-817 Clinical Study Report R&D/17/0779
- Efficacy of Elagolix in the Treatment of Endometriosis
- Study Protocol and Statistical Analysis Plan
- Gonadotropin-Releasing Hormone Antagonists - Orilissa™ (Elagolix Tablets)
- 214846Orig1s000
- Oriahnn (Elagolix/Estradiol/Norethindrone
- Standard Commercial Drug Formulary Prior Authorization Guidelines
- Oral Gonadotropin-Releasing Hormone Antagonists NOTICE
- Elagolix, Estradiol, and Norethindrone Acetate) Effective 11/01/20
- M12-821 Clinical Study Report R&D/16/0647